Analysis of Risk Factors Associated with Parkinson's Disease in Li Region in Hainan Area of China
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v3i2.855
Abstract
Objective — To analyse the risk factors associated with Parkinson's patients of Li ethnic groups in Hainan area. Methods — A retrospective survey study was conducted to select 81 cases of Parkinson's disease patients of Li ethnicity (Parkinson's group) and 110 cases of healthy population of Li ethnicity (control group), respectively, to collect data and conduct statistical analysis. Results — (1) GLU, UA, TG, HDL, LDL, Cys-C, Scr, BUN, ApoA, ApoB in the Li Parkinson's disease group were not statistically significant (P>0.05) compared with the control group. TC, Hcy and ApoB were significantly higher in the Li Parkinson's disease group than in the control group, and the differences were statistically significant (P<0.05). (2) Through Binary logistic regression analysis, the results showed that hypertension, TC and Hcy may be risk factors for the development of PD in the Li population. Conclusion — A history of hypertension and elevated cholesterol and homocysteine levels are independent risk factors for Parkinson's disease in Li patients in Hainan area.
Keywords
Parkinson's disease, risk factors, blood glucose, cholesterol, apolipoprotein a, apolipoprotein b, creatinine
Funding
Undergraduate Innovation and Entrepreneurship Training Program of Hainan Medical University research grants X202111810077. Project name: Correlation analysis of risk factors for Parkinson's syndrome in Li-Han ethnic groups in Hainan
Full Text
PDF - Viewed/Downloaded: 15 TimesReferences
[2]Dong MX, Feng X, Xu XM, et al. Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression. front Mol Neurosci. 2018;31(11):257.
[3]Hughes A J, Daniel S E, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.[J]. Journal of Neurology, 1992.
[4]Adler CH, Beach TG, Hentz JG, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014;83(5):406-12.
[5]Cassani E, Cereda E, Barichella M,et al.Cardiometabolic factors and disease duration in patients with Parkinson's disease. Nutrition. 2013;29(11-12):1331-5.
[6]García-Sanz P, Orgaz L, Bueno-Gil G, et al. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease. mov Disord. 2017;32(10):1409-1422.
[7]Wang K, Luo Z, Li C, Huang X,et al. Blood Cholesterol Decreases as Parkinson's Disease Develops and Progresses. j Parkinsons Dis. 2021;11(3):1177-1186.
[8]Li J, Gu C, Zhu M, Li D, et al. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease. Psychogeriatrics. 2020;20(2):180-188.
Copyright © 2022 Shuge Wang, Xinyao Sun, Cui Chen, Chenyu Yang, Wujian Xie, Na Lu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License